Logo-bi
Original Research
Wael A. Mahdi ORCID, Mohammad S. Absar, Suna Choi, Victor C. Yang, Young M. Kwon* ORCID
BioImpacts. 2022;12(6): 479-486. doi: 10.34172/bi.2022.23477
PMCID: PMC9809136     PMID: 36644546     Scopus ID: 85143309781    
The tPA was successfully modified via enzymatic oxidation by GO, resulting in enhanced control of its activity in the prodrug construct. This approach can be applied to other therapeutic glycoproteins.


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge